Design Therapeutics, Inc. (DSGN): S-3 filed Nov 4, 2026

Form type

S-3

Filing date

Nov 4, 2026

Accession number

0001193125-26-447545

Filer

Design Therapeutics, Inc. (CIK 1807120)